Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the ardio- ncology tudy roup of the eart ailure ssociation of the uropean ociety of ardiology in collaboration with the nternational ardio- ncology ociety